5-(4-Methoxyphenyl)-1-[4-(4-methoxyphenyl)thiazol-2-yl]-3-[4-(prop-2-ynyloxy)phenyl]-4,5-dihydro-1H-pyrazole

The title compound, C29H25N3O3S, crystallizes in the monoclinic space group P21/n. The molecule contains a central four-ring system in which all of the rings are almost coplanar. Both the 4-methoxyphenyl ring and the prop-2-ynyloxy substituent are disordered over two equivalent conformations with occupancy ratios of 0.903 (2):0.097 (2) and 0.776 (5):0.224 (5), respectively. In the crystal, π–π interactions [centroid–centroid distance = 3.7327 (11) Å] between the dihydropyrazole ring and the 4-methoxyphenyl ring link the molecules into centrosymmetric dimers. In addition, there are weak C—H...S, C—H...N and C—H...O interactions, which link the molecules into a complex three-dimensional array.